• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Modern prospects in the treatment of cancer of the breast and its metastasis. Medroxyprogesterone in massive doses as an alternative to polychemotherapy].

作者信息

Pannuti F

出版信息

Minerva Chir. 1977 Oct 15;32(19):1211-20.

PMID:593576
Abstract
摘要

相似文献

1
[Modern prospects in the treatment of cancer of the breast and its metastasis. Medroxyprogesterone in massive doses as an alternative to polychemotherapy].[乳腺癌及其转移治疗的现代前景。大剂量甲羟孕酮作为多药化疗的替代方案]
Minerva Chir. 1977 Oct 15;32(19):1211-20.
2
[Use of high doses of medroxyprogesterone acetate in the palliative treatment of advanced breast cancer. Clinical experience with 44 cases].[大剂量醋酸甲羟孕酮在晚期乳腺癌姑息治疗中的应用。44例临床经验]
Minerva Med. 1977 Dec 1;68(59):3967-80.
3
[Endocrine treatment of metastasizing breast cancer in menopausal women. A randomized comparison between tamoxifen (Nolvadex) versus tamoxifen and medroxyprogesterone acetate (Clinovir)].
Ugeskr Laeger. 1979 Jul 30;141(31):2113-6.
4
[Overall evaluation of the results of treatment of metastatic carcinomas of the breast with high doses of MAP combined with bromocryptin].[大剂量甲氨蝶呤、阿霉素和顺铂联合溴隐亭治疗转移性乳腺癌的疗效综合评估]
Minerva Med. 1980 Feb 25;71(6):391-400.
5
[Preliminary results of treatment of hormone-dependent metastatic carcinoma of the breast with the bromocriptin-medroxyprogesterone acetate combination].[溴隐亭-醋酸甲羟孕酮联合治疗激素依赖性转移性乳腺癌的初步结果]
Minerva Med. 1977 Jun 30;68(32):2233-44.
6
Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.醋酸甲羟孕酮（NSC - 26386）作为绝经后女性转移性乳腺癌二线激素治疗的疗效
Cancer Treat Rep. 1976 Mar;60(3):251-3.
7
Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients.
Chemioterapia. 1987 Dec;6(6):396-8.
8
[High-dose gestagen therapy with medroxyprogesterone acetate in metastasizing breast carcinoma].[醋酸甲羟孕酮高剂量孕激素疗法用于转移性乳腺癌]
Med Welt. 1983 Mar 25;34(12):378-82.
9
[Therapeutic effects of medroxyprogesterone acetate in recurrent or advanced breast cancer].
Gan To Kagaku Ryoho. 1985 Mar;12(3 Pt 1):516-23.
10
Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
Am J Clin Oncol. 1982 Oct;5(5):495-9.

引用本文的文献

1
The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer.高剂量醋酸甲羟孕酮（MPA）治疗晚期乳腺癌的药代动力学
Cancer Chemother Pharmacol. 1982;8(1):77-81. doi: 10.1007/BF00292875.
2
High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapy.
Cancer Chemother Pharmacol. 1979;2(3):175-80. doi: 10.1007/BF00258291.
3
[Current status in the treatment of breast cancer. I. Endocrine management--change of concepts and outlook for the future (author's transl)].
Klin Wochenschr. 1979 Sep 17;57(18):913-20. doi: 10.1007/BF01478547.